Tripelennamine
Back to searchMolecule Structure
Scientific Name
Tripelennamine
Description of the Drug
Tripelennamine is a histamine H1 antagonist used to treat hypersensitivity reactions, coughs, and the common cold.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00792
http://www.drugbank.ca/drugs/DB00792
Brand Name(s)
Not Available
Company Owner(s)
Parke Davis Div Warner Lambert Co, Heather Drug Co Inc, Nylos Trading Co Inc, Watson Laboratories Inc, Lannett Co Inc, Barr Laboratories Inc, Novartis Pharmaceuticals Corp, Anabolic Inc, Impax Laboratories Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Histamine H1 receptor | SINGLE PROTEIN | ANTAGONIST | CHEMBL231 |
Clinical Trial(s)
Unichem Links
| Atlas | tripelennamine | ||
| SureChEMBL | SCHEMBL17970 | ||
| PharmGKB | PA164764429 | ||
| Human Metabolome Database | HMDB0014930 | ||
| DrugBank | DB00792 | ||
| PubChem: Thomson Pharma | 14847861 | ||
| PubChem | 5587 | ||
| Mcule | MCULE-1679949518 | ||
| LINCS | LSM-3271 | ||
| Nikkaji | J4.349D | ||
| BindingDB | 81471 | ||
| EPA CompTox Dashboard | DTXSID8023717 | ||
| DrugCentral | 2762 | ||
| ChemicalBook | CB5875795 | ||
| Guide to Pharmacology | 7318 | ||
| rxnorm | TRIPELENNAMINE | TRIPELENNAMINE CITRATE | TRIPELENNAMINE HYDROCHLORIDE |
| KEGG Ligand | C07180 | ||
| ChEBI | 9741 | ||
| ZINC | ZINC000019117728 |
